Shareholding2 Sept 2026, 11:11 am
Amol Mujumdar Acquires 0.19% Stake in Goldline Pharmaceutical
AI Summary
Amol Laxmikant Mujumdar, Promoter and Managing Director of Goldline Pharmaceutical Limited, has acquired 18,000 equity shares, representing 0.19% of the total paid-up share capital. The acquisition was made through open market purchases on September 1, 2026. Following this transaction, Mujumdar's total holding in the company increased to 29.46%. This disclosure is made in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Key Highlights
- Promoter and MD acquired 18,000 shares.
- Acquisition represents 0.19% of total paid-up capital.
- Total promoter holding now stands at 29.46%.
- Transaction executed via open market purchase.
- Disclosure filed under SEBI (SAST) Regulations, 2011.
Price Impact
More from GLPL